Celldex Therapeutics, Inc. Announces Upcoming Presentation At The 2015 Leerink Global Healthcare Conference

HAMPTON, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief Executive Officer, and Tom Davis, M.D., Executive Vice President and Chief Medical Officer, are scheduled to present a corporate overview at the 2015 Leerink Global Healthcare Conference on Thursday, February 12, 2015 at 10:20 am ET at the Waldorf Astoria in New York City.

A live webcast of the presentation will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available through February 19, 2015.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.

CONTACT: Celldex Company Contacts: Investors: Sarah Cavanaugh Vice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 scavanaugh@celldex.com or Media: Dan Budwick Pure Communications, Inc. (973) 271-6085 dan@purecommunicationsinc.com

Help employers find you! Check out all the jobs and post your resume.